Panelists of the FDA's Circulatory Systems Devices Panel vote 13-1 in favor of approving Boston Scientific's Watchman anti-stroke cardiac implant.
The FDA's Circulatory Systems Devices Panel today voted 13-1 to recommend approval of Boston Scientific's(NYSE:BSX) Watchman 1st-of-its-kind left atrial appendage (LAA) closure device for reducing the risk of stroke and systemic embolism.
If you read nothing else today, make sure you're still in the know with MassDevice +3.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.